The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.25
Bid: 39.00
Ask: 39.30
Change: 0.65 (1.68%)
Spread: 0.30 (0.769%)
Open: 37.00
High: 40.00
Low: 37.00
Prev. Close: 38.60
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share options

16 Apr 2009 10:48

RNS Number : 6736Q
Alliance Pharma PLC
16 April 2009
 



For Immediate Release

16 April 2009

ALLIANCE PHARMA PLC

("the Company")

Share Options

Alliance Pharma plc (AIM: APH)the speciality pharmaceutical company, announces that on 14 April 2009 it awarded the following options over ordinary shares of the Company to certain Directors.

Name

Position

Number of options awarded

Exercise price per share

Date of vesting

Percentage of issued ordinary share capital

Tony Booley

Sales & Marketing Director

110,000

7.75p

14 April 2012

0.07%

Richard Wright

Finance Director

113,000

7.75p

14 April 2012

0.07%

For further information: 

Alliance Pharma plc
+ 44 (0) 1249 466966
John Dawson, Chief Executive
 
Richard Wright, Finance Director
 

www.alliancepharma.co.uk

 
 
 
Buchanan Communications
+ 44 (0) 20 7466 5000
Mark Court / Rebecca Skye Dietrich / Stasa Filiplic
 
 
 
Numis Securities
+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Brent Nabbs
 
Corporate Broking: David Poutney
 

 

Notes to editors

About Alliance Pharma

Alliance Pharma, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, WiltshireUK. The company has a strong track record of acquiring the rights to established niche brands and owns, or licences, the rights to 35 branded pharmaceutical products and continues to explore opportunities to expand the range.

Alliance Pharma's products are prescribed in the treatment of a wide range of conditions and include brands used in the treatment of dermatological conditions, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections. Alliance Pharma's sales are mainly prescription driven. Its products are distributed to hospitals directly and to pharmaceutical wholesalers which service both hospital and retail pharmacies with their prescription requirements.

Alliance Pharma joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUNSKRKSRSARR
Date   Source Headline
23rd Feb 20237:00 amRNSNotification of Full Year Results
1st Feb 20237:00 amRNSAppointment of NED and SID
30th Jan 20235:18 pmRNSNotification of Major Holdings
17th Jan 20237:00 amRNSFull Year Trading Update
16th Jan 20233:35 pmRNSNotification of Major Holdings
12th Jan 20237:00 amRNSSenior Management and Board Update
3rd Jan 202311:01 amRNSNotification of Major Holdings
29th Dec 202211:45 amRNSBlock Listing Six Monthly Return
22nd Dec 20229:51 amRNSNotification of Major Holdings
13th Dec 20224:58 pmRNSNotification of Major Holdings
23rd Nov 20227:00 amRNSUpdate on Q4 Trading
23rd Nov 20227:00 amRNSManagement Update
1st Nov 20225:33 pmRNSTotal Voting Rights
4th Oct 20224:48 pmRNSTotal Voting Rights
3rd Oct 20221:53 pmRNSNOTIFICATION OF MAJOR HOLDINGS
30th Sep 20224:07 pmRNSGrant of Options to Directors
20th Sep 20227:00 amRNSInterim Results
2nd Sep 20227:06 amRNSUpdate on CMA investigation
1st Sep 20225:03 pmRNSTotal Voting Rights
1st Sep 20227:00 amRNSNotification of Half Year Results
17th Aug 20221:21 pmRNSNotification of Major Holdings
17th Aug 20227:00 amRNSNotification of Major Holdings
8th Aug 20227:00 amRNSChange of Auditor
1st Aug 20226:02 pmRNSTotal Voting Rights
20th Jul 20227:00 amRNSHalf Year Trading Update
1st Jul 202210:14 amRNSTotal Voting Rights
30th Jun 202210:14 amRNSBlock Listing Six Monthly Return
17th Jun 20224:00 pmRNSBlock Admission Application
8th Jun 20227:00 amRNSTotal Voting Rights
26th May 20227:00 amRNSNotification of Major Holdings
18th May 20223:42 pmRNSResult of AGM
18th May 20227:00 amRNSDirectorate Changes
18th May 20227:00 amRNSAGM Statement
3rd May 20221:18 pmRNSTotal Voting Rights
12th Apr 202211:30 amRNSPosting of Annual Report and Notice of AGM
6th Apr 202211:12 amRNSNotification of Major Holdings
5th Apr 202210:02 amRNSAnnual Report and Notice of AGM
4th Apr 202211:17 amRNSTotal Voting Rights
25th Mar 202210:48 amRNSAcquisition to access US scar treatment market
22nd Mar 20227:00 amRNSResults for the year ended 31 December 2021
21st Mar 20221:30 pmRNSStatement regarding potential acquisition
15th Mar 20224:15 pmRNSNotification of Major Holdings
1st Mar 20223:32 pmRNSTotal Voting Rights
15th Feb 20227:00 amRNSNotification of Full Year Results
3rd Feb 20222:42 pmRNSNotification of Major Holdings
3rd Feb 20227:09 amRNSUpdate on CMA investigation
1st Feb 20224:32 pmRNSTotal Voting Rights
18th Jan 20227:30 amRNSNotification of Major Holdings
18th Jan 20227:00 amRNSFull Year Trading Update
4th Jan 20226:04 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.